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Introduction: AIDS therapeutic targets principally consists of three enzymes: 
reverse transcriptase (RT), protease (PR) and integrase (IN). Integrase strand transfer 
inhibitors among the HIV inhibitors has the advantage of suitable safety profile and 
high potency. The chelating motif and coplanar hydrophobic aryl group are the 
common pharmacophores of an integrase strand transfer inhibitor (INSTI). 
According to the cyclic chelating group of dolutegravir, we incorporated the 
chelating group into a cyclic motif and novel 2-mercaptooxazoloxocumarin tricyclic 
scaffold was designed. Hydrophobic part of the ligand was attached through s-
arylation to occupy the same position as the halobenzyl pharmacophoric group of 
INSTIs. 
Methods and Results: 4-Hydroxy-3-nitro coumarin was prepared in a nitration 
procedure of 4-hydroxy coumarin with the aid of concentrated nitric acid and 
sulfuric acid. Reduction of the 4-hydroxy-3-nitro coumarin in the presence of 
sodium dithionite and sodium acetate in water gave the 3-amino-4-hydroxy 
coumarin. 2-Mercaptooxazolocoumarin was prepared by the reaction of carbon 
disulfide with 3-amino-4-hydroxy coumarin in methanolic potassium hydroxide. 
Then, this intermediate was treated with substituted benzyl halides in the presence of 
potassium carbonate and acetone. Final derivatives were recrystallized from ethanol 




CNMR. According to the docking 
results, the tricyclic scaffold could п-stack the 3’-end reactive adenosine in the IN 
active site just same as the co-crystallized ligand dolutegravir and the ligand 
heteroatoms complexes the magnesium cofactors in the IN. 
Conclusions: Here, we introduced a novel scaffold for anti-HIV activity. The 
superimposed structure with co-crystallized ligand dolutegravir confirmed the 
potential for integrase inhibitory activity just same as the second generation 
integrase inhibitor dolutegravir. 
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